24-012909 nhlbi requires the filing of a national stage application in europe in order to pursue rights in "preparation of isotopically labeled ketoglutarates and methods of hyperpolarization…
Ended Awarded Last action
- Contract number
- 75N92024F00019
- Awardee
-
Leydig, Voit & Mayer, LTD. UEI EBWMLJZ4ZTY3
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,301
Award facts
- Opportunity
-
- 20LVMCHM009224 Solicitation number
- Contract value 100% obligated
- $10,301.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541110 Offices of Lawyers
- PSC
- R418 Support- Professional: Legal
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Chicago, IL 60601, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for services related to intellectual property activities in support of biomedical research and technology development at the National Institutes of Health (NIH). The prime contractor, Leydig, Voit & Mayer, LTD., is an internationally recognized law firm specializing in patent-related services. The contract, issued as a Delivery Order under the NIH Patent Legal Services indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle, has a ceiling value of $10,301.00 and a period of performance ending on October 1, 2024. The award does not have a set-aside designation. Leydig, Voit & Mayer provides a range of legal services to the NIH and other Department of Health and Human Services agencies, including preparing and filing patent applications, prosecuting patents, and providing general intellectual property counsel. This contract supports the National Heart, Lung, and Blood Institute's (NHLBI) efforts to pursue patent rights for an invention related to the preparation of isotopically labeled ketoglutarates and hyperpolarization techniques.
Description
24-012909 nhlbi requires the filing of a national stage application in europe in order to pursue rights in "preparation of isotopically labeled ketoglutarates and methods of hyperpolarization through signal amplification by reversible exchange (
Quick answers
Who was awarded contract 75N92024F00019?
75N92024F00019 was awarded to Leydig, Voit & Mayer, LTD. by National Heart Lung and Blood Institute (National Institutes of Health) on July 2, 2024.
How much is contract 75N92024F00019 worth?
The government has obligated $10,301 on 75N92024F00019.
Is contract 75N92024F00019 an order under another contract?
Yes. 75N92024F00019 is a delivery order under 75N98020D00053, an indefinite delivery contract, on NIH Patent Legal Services.
Was contract 75N92024F00019 competed?
The extent of competition for 75N92024F00019 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award